KOREA LIFE SCIENCE WEEK

HOME KOREA LIFE SCIENCE WEEK > Exhibitors Search > 상세

2020 Exhibitors Search

GENEmedicine

Booth no. C21

Exhibit Item	[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
Country	Korea, South
Tel (Rep.)	02-6214-3237
Website	http://www.gene-medicine.com

Company Introduction

GeneMedicine is a company specializing in the development of oncolytic virus through state-of-the-art genetic engineering. Our company has developed and patented a nano material-based platform technology that allows efficient and tumor-targeted delivery of oncolytic virus by systemic administration. GM101 has completed phase 1 clinical trial and further clinical development is underway, aiming for drug approval by 2024. GM102, 103 will begin their respective clinical trial in 2021 and 2022.

Exhibit Item

	Exhibit Name : Oncolytic adenovirus GM101, GM102, GM103 Commercialized oncolytic viruses and those under clinical development have several inherent limitations that limit their overall therapeutic efficacy.GeneMedicine's patented oncolytic viruses under preclinical and clinical development can address the limitations of existing oncolytic viruses, targeted cancer therapeutics,cancer immunotherapeutics.
	Exhibit Name : product name : undecided undecided
	Exhibit Name : product name : undecided undecided
	Exhibit Name : product name : undecided undecided
	Exhibit Name : product name : undecided undecided

Exhibit Description

Commercialized oncolytic viruses and those under clinical development have several inherent limitations that limit their overall therapeutic efficacy.GeneMedicine's patented oncolytic viruses under preclinical and clinical development can address the limitations of existing oncolytic viruses, targeted cancer therapeutics,cancer immunotherapeutics.

Co-Exhibitor or
Partner’s Information

Company Name	Country	Website
.
.
.

List